GAVI Alliance pours $100M into meningitis vaccine

The GAVI Alliance has committed $100 million to support a meningitis A vaccine called MenAfriVac developed by Seattle-based PATH. The vaccine, which was developed with the help of a $70 million donation from the Bill and Melinda Gates Foundation, has already been introduced in Burkina Faso, Mali and Niger. The funding includes $72.6 million to purchase MenAfriVac vaccines and $27.6 million for operational costs. Release

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.